Skip to main content

Table 3 NPC patients with late-infantile (LI) form of disease

From: Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years

P

G

Sb/Cs

Year of dg

Age at death (†)/age at last follow up

First visceral symptoms (age)

First neuro-psychiatric symptoms (age)

BMS (Y/ND)

Filipin and CEL or CE (Y/ND)

Histology and AT (Y/ND)

Mutations (NPC1)Predicted effect on protein

Age at dg

1

M

B of 2/T3

1975

11y (†)

NR

PMRt (3 y)

ND

ND

Y (AT)

ND

DPM

2

M

B of 1/T3

1975

9y (†)

NR

SRt, Epi (3 y)

ND

ND

Y (AT)

ND

DPM

3

M

0

1975

8y (†)

NR

PMRg, Epi (3 y)

ND

ND

Y (AT)

ND

DPM

4

F

S of 14/T4

1975

? (†)/4y

HSm (4 m)

PMRg, A (4y)

ND

ND

Y

ND

4y

5

M

0

1981

5y (†)

HSm (1 m)

PMRt (3y)

Y

ND

Y (AT)

c.1421C>T/c.3557G>A††

3y

p.P474L/p.R1186H

6

F

0

1988

19y (†)

HSm (2y)

PMRg (6y)

Y

Y (CE)

Y

c.2635_2636dupAT/ c.3019C>G

6y

p.Q881Vfs*56/p.P1007A

7

F

0

1990

11y (†)

HSm (4y)

A, Ds, GCt (4 y)

Y

Y (F/V)

ND

c.1029dupG/c.3019C>G

8y

p.S344Vfs*35/p.P1007A

8

F

0

1993

12 (†) y

NJa (1 m)

A, Ds, Epi (4y)

Y

Y (F/C)

ND

c.3182T>C/NDT

10y

p.I1061T/NDT

9

M

0

1995

22y (†)

HSm (5y)

PMRt (5y)

Y

Y (F/I)

ND

c.3019C>G/c.3557G>A

5y

p.P1007A/p.R1186H

10

M

B of 10/T2

1998

?(†) /4y

HSm (1 m)

SRt (4 y)

ND

Y (F/C)

ND

c.826T>C/c.3557G>A

4y

p.Y276H/p.R1186H

11

M

0

2004

10y

HSm (7 m)

A, GCt (4y)

ND

Y (F/C)

ND

c.3182T>C/c.3557G>A

4y

p.I1061T/p.R1186H

12

M

0

2008

12 (†)

Sm (6y)

A, PMRg (3y)

Y

ND

ND

c.3557G>A/c.3557G>A

6y

p.R1186H/p.R1186H

13

M

B of 12/T2

2009

6y (†)

NJa (1 m)

A, GCt (4y)

Y

ND

ND

c.2196dupT /c.3557G>A

4y

p.P733Sfs*9 /p.R1186H

  1. A ataxia, AT autopsy, B brother, BMS bone marrow smear, CE non-LDL-cholesterol esterification test, CEL LDL-cholesterol esterification test, Cs cousin, dg diagnosis, DPM delayed post-mortem examination (in preserved tissues, Ds dysartria, Epi epilepsia, F female, F/C classical biochemical subtype using filipin staining + CEL, F/I intermediate biochemical subtype using filipin staining + CEL, F/V variant biochemical subtype using filipin staining + CEL, G gender, GCt gelastic cataplexy, HSm hepatosplenomegaly, m months, M male, ND not done, NDT not detected, NJa neonatal jaundice, NR not reported, P order of patient at the category; PMRg psychomotoric regression, PMRt psychomotoric retardation, S sister, Sb sibling, Sm splenomegaly, SRt speech retardation, T table, y years, Y Yes, † patient deceased, †† genotype determined indirectly based on parents’ genotype, *translation stop codon in 1-letter amino acid code. Note: novel mutations are highlighted in bold font, and italics indicate decisive diagnostic method or methods (if they were performed simultaneously or in quick succession).